MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$97,503K
(14.38%↑ Y/Y)
Interest income
$5,205K
(-39.50%↓ Y/Y)
Net loss
-$96,231K
(15.83%↑ Y/Y)
Unrealized (loss) gain on
marketable securities
-$1,272K
(-381.42%↓ Y/Y)
Total other income,
net
$4,301K
(-33.61%↓ Y/Y)
Change in fair value of
investments, net
-$904K
(57.46%↑ Y/Y)
Operating loss
-$100,532K
(16.78%↑ Y/Y)
Collaboration revenue
$15,048K
(-9.50%↓ Y/Y)
Total operating
expenses
$115,580K
(-15.90%↓ Y/Y)
Research and development
$80,737K
(-25.54%↓ Y/Y)
General and
administrative
$34,843K
(20.12%↑ Y/Y)
Back